| NDC Code | 51144-050-01 |
|---|
| Package Description | 1 VIAL, SINGLE-DOSE in 1 BOX (51144-050-01) / 10.5 mL in 1 VIAL, SINGLE-DOSE |
|---|
| Product NDC | 51144-050 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Adcetris |
|---|
| Non-Proprietary Name | Brentuximab Vedotin |
|---|
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20110825 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA125388 |
|---|
| Manufacturer | SEAGEN INC. |
|---|
| Substance Name | BRENTUXIMAB VEDOTIN |
|---|
| Strength | 50 |
|---|
| Strength Unit | mg/10.5mL |
|---|
| Pharmacy Classes | CD30-directed Antibody Interactions [MoA], CD30-directed Immunoconjugate [EPC], Immunoconjugates [CS], Microtubule Inhibition [PE] |
|---|